TTMI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
TTMI is not a good buy right now for an impatient buyer. The trend is bullish, but the stock is sitting right at the pivot (~98.44) with near-term resistance overhead (103.79), options are pricing elevated volatility (IV percentile ~82), and insider selling has surged (+770% last month). With no Intellectia buy signals today and pattern-based odds pointing to mild-to-moderate weakness over the next month (-3.99%), I would not chase at ~$98; this is a HOLD/avoid-new-buy here.
Trend/structure: Bullish moving-average stack (SMA_5 > SMA_20 > SMA_200) confirms an ongoing uptrend. Momentum: MACD histogram is positive (0.0923) but positively contracting, suggesting upside momentum is fading rather than accelerating. RSI: RSI(6) ~66.1 (upper-neutral), consistent with strength but not a fresh oversold entry. Levels: Price is essentially at the pivot (98.444). Near resistance: R1 103.786 then R2 107.087. Supports: S1 93.102 then S2 89.801. Risk/reward is less attractive at the pivot (closer to resistance than support) for a quick-entry buyer. Quant/pattern overlay: Similar-pattern read shows a 70% chance of slight weakness next day/week and a larger -3.99% bias over the next month, aligning with the idea that upside may be limited in the immediate term.
on 2026-02-09 after hours (Street EPS est. ~0.
could move the stock if results/guide surprise upward.
is meaningful.
Latest reported quarter: 2025/Q3. Growth: Revenue rose to ~$752.7M (+22.09% YoY). Profitability improved sharply: net income ~$53.1M (+270.73% YoY) and EPS $0.50 (+257.14% YoY). Margin: Gross margin slipped slightly to ~19.91% (down ~0.15% YoY), implying growth is strong but margin expansion is not the primary driver. Overall: Strong top-line acceleration and major earnings leverage support the longer-term bull case, but they don’t remove the near-term ‘buy-right-now’ timing issues at current levels.
Recent trend: Ratings remain Buy-leaning with multiple price target raises. Key changes: Needham raised PT to $79 (Nov 2025) on data-center computing momentum; B. Riley raised PT to $81 (Dec 2025) on gen-AI PCB demand; Truist raised PT to $91 (Dec 2025) on 2027 estimate framework; B. Riley dramatically raised PT to $123 (Jan 2026) citing management’s 15–20% annual revenue growth outlook and earnings doubling by 2027. Wall Street pros: Strong AI/data-center demand tailwinds, increasing PCB complexity, and management/analyst confidence in multi-year growth. Wall Street cons: Execution and ramp/capacity scaling risk (implied by focus on factory expansions), plus near-term volatility around earnings and the stock’s extended move. Influential/political trading: No recent congress trading data available; no politician/influential buys/sells were provided.
